New care approach aims to help seniors bounce back after colon cancer surgery
NCT ID NCT05993923
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a special geriatric care program before and after colorectal cancer surgery helps patients aged 70 and older recover their daily functioning better than standard care. The program includes early nutrition support, early mobilization, and careful management of other health issues. Researchers will compare functional status at 3 months between the two groups.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- multidisciplinary geriatric perioperative care program
- What this could lead to
- If it works, this could show that a tailored geriatric care plan helps older adults recover their independence faster after colorectal cancer surgery.
- What could go wrong
- This is a small, early-stage trial with only 90 participants, so results may not apply to all older adults. The intervention is complex and may be hard to replicate in other hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2023
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
70 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The patient or their representative must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Diagnosis of proven colorectal cancer. * Patient to benefit from scheduled colorectal surgery at the University Hospital of Nîmes validated in digestive surgery SPC after oncogeriatric evaluation. * Surgical act: resection with anastomosis in one step. Exclusion Criteria: * Interventional RIPH patient defined as category 1 if there is interference with the primary endpoint * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU de Nîmes
RECRUITINGNîmes, 30029, France
-
CHU de Nîmes
NOT_YET_RECRUITINGNîmes, France
-
Coralie LABARIAS
RECRUITINGNîmes, France, 30029, France
-
Coralie LABARIAS
RECRUITINGNîmes, France, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- An equity focused intervention to improve utilization of guideline concordant extended venous thromboembolism prophylaxis after major cancer surgery
- Ivosidenib plus mFOLFOXIRI and celecoxib as a treatment for BRAF-targeted therapy-refractory BRAF V600E-mutant colorectal cancer patients: a phase II study
- Can a new drug shrink advanced solid tumors?
- Can a new drug shrink tumors that resist standard care?
- Propofol vs. inhaled anesthesia: which one spares your recovery?
- Can a Mini-Dose drug combo rescue Post-Surgery sleep for sleep apnea patients?